Skip to main content
. 2024 Feb 12;30(3):730–739. doi: 10.1038/s41591-023-02791-w

Extended Data Fig. 6. Response rates by RAS/BRAF and MSS status.

Extended Data Fig. 6

Response rates in (a) patients with left-sided primary tumors, (b) patients with right-sided primary tumors and (c) the overall population (all ctDNA-evaluable patients). Data plotted are percentages of patients with a response ± 95% CIs. ORs were calculated by logistic regression analysis. Statistical tests were two-sided without adjustment for multiple comparisons. mFOLFOX6, modified FOLFOX6; MSI-H, microsatellite instability–high; MSI-L, microsatellite instability–low; MSS, microsatellite stable; OR, odds ratio; WT, wild type.